Melanoma
A closely watched experimental drug has come through with a 63% reduction in the relative risk of death from metastatic melanoma when compared with standard therapy in a phase III trial that had enrolled 675 newly diagnosed patients.
Recommended Products for:Melanoma
Melanoma Awareness Ribbon Business Card Holder 
The Melanoma Ribbon proudly displayed on a business card holder. There is no better way to achieve remembrance and awareness for t…
Prepackaged (7 3/4 in.) Cancer Awareness Bracelet 18 Colors, 8mm Product Description
Our Bracelets are Handmade in the USA. Made with 8mm cats eye beads (the red bead here is a glass pearl, not a…
Melanoma on Human Skin Photographic Poster Print by Ken Greer, 30×40 Melanoma on Human Skin is digitally printed on archival photographic paper resulting in vivid, pure color and exceptional detail …
Surgery in Breast Cancer and Melanoma: Handbooks in General Surgery Surgery in Breast Cancer and Melanoma provides an illustrative, instructive, and comprehensive review that depicts the rationale o…
Pathology of Malignant Melanoma An excerpt from “Pathology of Melanocytic Nevi and Malignant Melanoma, Second Edition”, Pathology of Malignant Melanoma provides a…
Melanoma And Other Skin Cancer [VHS] This video provides the patient and care giver with a comprehensive overview of melanoma and related skin cancers by international…
Related Topics
Tags: Advanced, BRAF, Cuts, death, Inhibitor, MELANOMA, Risk